SAO Equity Snapshot

TAKP34 Weekly Equity Report

Takeda Pharmaceutical Company Limited

Interactive chart JSON snapshot
Latest Close 76.32 BRL 12 Jun 2026
1W Return 0.0% latest completed week
4W Return -5.5% short-term follow-through
12W Return -18.7% quarterly tape
Trend Breadth 42.3% 22 of 52 weeks active
Volume Ratio - vs 13-week average
Company Brief

What the company does

Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma-derived therapies, immunology, oncology, and neuroscience. The company provides its products under the Entyvio, Gattex/Revestive, Takecab/Vocinti, EOHILIA, Alofisel, Dexilant, Pantoloc/Controloc, Adynovate/Adynovi, Feiba Fiber, Recombinate, Hemofil, Immunate, Immunine, Takhzyro, Livtencity, ADZYNMA, Elaprase, Replagal, Advate, Flexbumin, Vpriv, Gammagard Liquid/Kiovig, Hyqvia, Cuvitru, Exkivity, FRUZAQLA, Ninlaro, Velcade, Azilva, Iclusig, Leuplin/Enantone, Adcetris, vyvanse/elvanse, Trintellix, QDENGA, and Alunbrig brands. It has in-licensing agreements with BioMarin, Luxna Biotech, GlaxoSmithKline, Halozyme, and …

Snapshot

What the weekly tape is saying

TAKP34 closed the latest completed week at 76.32 BRL. The 4-week return is -5.5% and the 12-week return is -18.7%. Trend Signal is inactive, Market Dynamics is -1.06. Setup signature: Risk-first tape with a 21/100 composite read.

Trend Signal Inactive
Market Dynamics No fresh buy
Price vs Trend -10.0%
Volume -
Setup Cockpit

A compressed read of the whole setup

The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.

Composite setup radar

Scoreboard

Trend 23 Persistence of active Trend Signal over the last year and current streak.
Momentum 21 Blend of 4-week and 12-week follow-through.
Dynamics 28 Latest Market Dynamics and whether pressure has improved over four weeks.
Relative Strength 12 Relative leadership and short-term RS change.
Volume 0 Participation compared with the 13-week volume baseline.
Risk Control 45 Drawdown and recent weekly volatility pressure.

16-week signal tape

27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun
Weekly return bar Trend Signal dot Positive Market Dynamics dot
Price Action

Price, Trend Line, and Fair Value

Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.

52-week price path

Price Trend Line Fair Value

Price map

Trend Line
84.80 BRL
Vs Trend Line
-10.0%
Fair Value
74.79 BRL
Vs Fair Value
2.0%
52W High
95.30 BRL
52W Low
69.74 BRL
Drawdown
-19.9%
Range Position
25.7%
Momentum

Returns and trend persistence

Return windows separate the latest week from short-term and medium-term follow-through.

Return windows

1W 0.0%
4W -5.5%
12W -18.7%
26W -1.5%
52W -5.8%

Trend read

Active Streak
0 weeks
52W Active Weeks
22
52W Active Breadth
42.3%
Sector Scope
BR Healthcare
Sector Rank
46 of 80
Sector Percentile
43.0%
Peer Context

Sector and industry pulse

Peer breadth helps separate a stock-specific move from a broader group rotation.

Market Dynamics

Pressure, Relative Strength, and expectation

Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.

Dynamics path

Market Dynamics Relative Strength

Signal state

Market Dynamics
-1.06
4W MD Change
-39.3%
Relative Strength
-12.62
4W RS Change
-0.5%
Expectation
Undecided
Probability
49.86%
Volume

Participation and confirmation

Volume tells us whether the latest weekly move is being confirmed by unusual participation.

52-week volume profile

Volume map

Latest Volume
0
13W Average
1
52W Average
53
Vs 13W
-
Vs 52W
-
Risk Anatomy

Volatility, downside weeks, and return shape

A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.

26-week return distribution

Risk map

13W Volatility
2.9%
52W Volatility
3.5%
Upside Weeks
19
Downside Weeks
16
Downside Breadth
30.8%
Avg Gain / Loss
3.0% / -3.8%
Context

Classification, opportunities, risks, and watch points

Top-level read across company classification, constructive evidence, caution points, and the next things that matter.

Classification

Exchange
SAO
Country
BR
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Currency
BRL
Market Cap
256.3B

Opportunity signals

  • Price is above Fair Value, showing premium demand versus the model.

Risk signals

  • Trend Signal is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Market Dynamics is negative, which weakens the current setup.

Watch next

  • Trend Line remains the key weekly regime level.
  • Market Dynamics is the pressure gauge to monitor for confirmation or fade.
Weekly Tape

Recent completed weeks

The latest weekly rows behind the report snapshot.

Week Close Return Trend Fair Value MD RS Volume Signal
12 Jun 2026 76.32 BRL 0.0% 84.80 BRL 74.79 BRL -1.06 -12.62 0 Off
5 Jun 2026 76.32 BRL -5.9% 84.66 BRL 74.75 BRL -1.03 -12.01 2 Off
29 May 2026 81.12 BRL 0.5% 84.52 BRL 74.72 BRL -1.02 -9.53 1 Off
22 May 2026 80.72 BRL 0.0% 84.16 BRL 74.66 BRL -1.00 -11.66 0 Off
15 May 2026 80.72 BRL -1.5% 83.96 BRL 74.61 BRL -0.76 -12.56 2 Off
8 May 2026 81.92 BRL -0.2% 83.76 BRL 74.56 BRL -0.50 -14.79 1 On
1 May 2026 82.08 BRL -8.2% 83.52 BRL 74.52 BRL 0.01 -16.62 4 On
24 Apr 2026 89.46 BRL 0.0% 83.34 BRL 74.48 BRL 0.43 -11.35 0 On
17 Apr 2026 89.46 BRL -4.1% 83.20 BRL 74.38 BRL 0.66 -14.11 1 On
10 Apr 2026 93.30 BRL -2.1% 82.82 BRL 74.29 BRL 0.84 -11.76 2 On
3 Apr 2026 95.30 BRL 1.5% 82.31 BRL 74.17 BRL 0.77 -6.06 0 On
27 Mar 2026 93.88 BRL 0.0% 81.84 BRL 74.06 BRL 0.76 -4.69 0 On
20 Mar 2026 93.88 BRL 1.8% 81.36 BRL 73.95 BRL 0.75 -2.23 1 On
13 Mar 2026 92.26 BRL 0.0% 80.95 BRL 73.83 BRL 0.75 -4.99 0 On